Skip to main content
Clinical Trials/ChiCTR-IOR-17012332
ChiCTR-IOR-17012332Not yet recruitingNot Applicable

血浆肾素活性指导降压药物选择的效果

自筹1 site in 1 country300 target enrollmentStarted: September 1, 2017Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
300
Locations
1
Primary Endpoint
血压达标率

Study Overview

Brief Summary

评价血浆肾素活性指导降压药物选择的治疗效果和预后

Study Design

Study Type
干预性研究
Primary Purpose
随机平行对照

Eligibility Criteria

Ages
18 to 75 (—)
Sex
All

Inclusion Criteria

  • 1、难治性高血压;2、年龄 18~75 岁;3、签署同意书。

Exclusion Criteria

  • 1、严重肝、肾疾病(GFR<30ml/1.73m2 和 ALT 正常值上限 2.5 倍者);2、 孕妇、哺乳期妇女或有妊娠意向者;3、 肿瘤; 4、继发性高血压;5、不能坚持随访或依从性较差者。

Arms & Interventions

对照组

传统方法选药

研究组

新方法选药

Outcomes

Primary Outcomes

血压达标率

Secondary Outcomes

  • 主要不良事件

Investigators

Sponsor
自筹

Study Sites (1)

Loading locations...

Similar Trials